EP0931834A3 - Echinocandin-bindungsdomäne von 1,3-Beta-glukan Synthase - Google Patents

Echinocandin-bindungsdomäne von 1,3-Beta-glukan Synthase Download PDF

Info

Publication number
EP0931834A3
EP0931834A3 EP98310497A EP98310497A EP0931834A3 EP 0931834 A3 EP0931834 A3 EP 0931834A3 EP 98310497 A EP98310497 A EP 98310497A EP 98310497 A EP98310497 A EP 98310497A EP 0931834 A3 EP0931834 A3 EP 0931834A3
Authority
EP
European Patent Office
Prior art keywords
glucan synthase
binding domain
echinocandin
beta
glucan
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP98310497A
Other languages
English (en)
French (fr)
Other versions
EP0931834A2 (de
Inventor
Doreen Ma
Colleen Kay Dixon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of EP0931834A2 publication Critical patent/EP0931834A2/de
Publication of EP0931834A3 publication Critical patent/EP0931834A3/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1048—Glycosyltransferases (2.4)
    • C12N9/1051—Hexosyltransferases (2.4.1)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
EP98310497A 1997-12-23 1998-12-21 Echinocandin-bindungsdomäne von 1,3-Beta-glukan Synthase Withdrawn EP0931834A3 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6865897P 1997-12-23 1997-12-23
US68658P 1997-12-23

Publications (2)

Publication Number Publication Date
EP0931834A2 EP0931834A2 (de) 1999-07-28
EP0931834A3 true EP0931834A3 (de) 2002-06-26

Family

ID=22083932

Family Applications (1)

Application Number Title Priority Date Filing Date
EP98310497A Withdrawn EP0931834A3 (de) 1997-12-23 1998-12-21 Echinocandin-bindungsdomäne von 1,3-Beta-glukan Synthase

Country Status (3)

Country Link
EP (1) EP0931834A3 (de)
JP (1) JPH11243977A (de)
CA (1) CA2255140A1 (de)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7709444B2 (en) 1999-03-03 2010-05-04 Pfizer Inc. Echinocandin pharmaceutical formulations containing micelle-forming surfactants
US7790744B2 (en) 1992-03-19 2010-09-07 Eli Lilly And Company Cyclic peptide antifungal agents and process for preparation thereof

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6506726B1 (en) 1998-12-09 2003-01-14 Eli Lilly And Company Purification of Echinocandin cyclopeptide compounds
BR0008713A (pt) 1999-03-03 2001-12-26 Lilly Co Eli Processos para preparar formulações ecomposições farmacêuticas orais com ecb
IL145187A0 (en) 1999-03-03 2002-06-30 Lilly Co Eli Echinocandin/carbohydrate complexes
US6991800B2 (en) 2002-06-13 2006-01-31 Vicuron Pharmaceuticals Inc. Antifungal parenteral products
US7119061B2 (en) 2002-11-18 2006-10-10 Vicuron Pharmaceuticals, Inc. Dalbavancin compositions for treatment of bacterial infections
US20050130909A1 (en) 2002-11-18 2005-06-16 Luigi Colombo Dalbavancin compositions for treatment of bacterial infections
US20060074014A1 (en) 2002-11-18 2006-04-06 Vicuron Pharmaceuticals Inc. Dalbavancin compositions for treatment of bacterial infections
ES2430553T3 (es) * 2005-07-26 2013-11-21 The University Of Medicine And Dentistry Of New Jersey Análisis de resistencia a fármacos de tipo equinocandinas
AU2012230095B2 (en) * 2005-07-26 2015-05-28 Merck Sharp & Dohme Corp. Assays for resistance to echinocandin-class drugs

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995010625A1 (en) * 1993-10-12 1995-04-20 Merck & Co., Inc. Dna encoding 1,3-beta-d glucan synthase subunits

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995010625A1 (en) * 1993-10-12 1995-04-20 Merck & Co., Inc. Dna encoding 1,3-beta-d glucan synthase subunits

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DOUGLAS C M ET AL: "Identification of the FKS1 gene of Candida albicans as the essential target of 1,3-beta-D-glucan synthase inhibitors", ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, vol. 41, no. 11, November 1997 (1997-11-01), United States, pages 2471 - 2479, XP000107858 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7790744B2 (en) 1992-03-19 2010-09-07 Eli Lilly And Company Cyclic peptide antifungal agents and process for preparation thereof
US7709444B2 (en) 1999-03-03 2010-05-04 Pfizer Inc. Echinocandin pharmaceutical formulations containing micelle-forming surfactants

Also Published As

Publication number Publication date
JPH11243977A (ja) 1999-09-14
EP0931834A2 (de) 1999-07-28
CA2255140A1 (en) 1999-06-23

Similar Documents

Publication Publication Date Title
WO2005051998A3 (en) Antibodies binding to a c-terminal fragment of apolipoprotein e
WO2000002917A3 (en) Compounds and methods for modulating cadherin-mediated functions
EP0930366A3 (de) Bindungsdomänen des Serrate-proteins
EP0823486A3 (de) Verfahren zur Hemmung der Bindung von DNA-Bindungsproteinen mit Duplex-DNA
WO1999047656A3 (en) Nucleic acid binding proteins
EP0931834A3 (de) Echinocandin-bindungsdomäne von 1,3-Beta-glukan Synthase
WO2003087129A3 (en) Immunogenic peptides, and method of identifying same
AU2002217010A1 (en) Peptides, the production and use thereof for binding immunoglobulins
WO2002016418A3 (en) An iap binding peptide or polypeptide and methods of using the same
AU1832797A (en) A polypeptide from lung extract which binds amyloid-beta peptide
AU4367196A (en) Novel protein domain which binds tyrosine phosphorylated proteins
CA2173102A1 (en) Dna sequence coding for a bmp receptor
WO2000050607A3 (en) Goodpasture antigen binding protein
WO1996035715A3 (en) Pcna binding substance
AUPP627498A0 (en) Novel peptides - i
WO1997044451A3 (en) Vasoactive amine binding molecules
GB2342652A (en) Polypeptides comprising a coiled-coil and an addition
WO2000037482A3 (en) Peptides and peptide analogues designed from hfe protein and their uses in the treatment of iron overload diseases
GB0024351D0 (en) Dye-labelled peptide and method
EP0816498A3 (de) Exzitatorische Aminosäure Rezeptor-Protein und verwante Nukleinsäure
CA2194032A1 (en) Fused dna sequence, fused protein expressed from said fused dna sequence and method for expressing said fused protein
CA2385766A1 (en) Methods for production of proteins in host cells
WO2001027630A3 (en) Methods to identify compounds that modulate neuronal activity
WO2001049714A3 (en) Nope polypeptides, encoding nucleic acids and methods of use
CA2329144A1 (en) New peptide fragments for protein purification

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19990120

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

PUAL Search report despatched

Free format text: ORIGINAL CODE: 0009013

AK Designated contracting states

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20020702

AKX Designation fees paid

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI NL PT SE